VEGF, Flt-1, and microvessel density in primary tumors as predictive factors of colorectal cancer prognosis
- 30 December 2016
- journal article
- Published by Spandidos Publications in Molecular and Clinical Oncology
- Vol. 6 (2) , 243-248
Abstract
Angiogenesis in the primary tumor is known to be necessary for tumor progression in adenocarcinomas of the colon. However, whether angiogenesis in the primary tumors of patients with colorectal cancer affects their prognosis has yet to be fully elucidated. The aim of the present study was to assess the association between selected pathoclinical parameters and overall survival of resectable colorectal cancer patients with the expression of angiogenesis‑promoting factors, including vascular endothelial growth factor (VEGF) and Fms‑like tyrosine kinase receptor (Flt‑1), and microvessel density (MVD) in the primary tumor. VEGF and Flt‑1 expression were assessed, as well as MVD (with anti‑CD34) by immunohistochemistry in 139 archived primary colorectal cancer tissue samples. These results were compared with the overall survival of the patients and potential prognostic pathoclinical parameters. A higher MVD in the tumors expressing Flt‑1 (P=0.04) was identified. However, there was no correlation between the pathoclinical parameters of colon cancer and Flt‑1 expression, VEGF expression, or MVD in the tumor. Furthermore, the intensity of VEGF expression, Flt‑1 expression and tumor MVD did not correlate with the overall survival of the patients. Therefore, although increased expression of VEGF and Flt‑1 was correlated with an increased expression of MVD in the primary tumors of resectable colorectal cancer patients, these factors were not correlated with prognostic pathoclinical factors and overall survival.Keywords
This publication has 34 references indexed in Scilit:
- Identification of the high-risk group for metastasis of gastric cancer cases by vascular endothelial growth factor receptor-1 overexpression in peripheral bloodBritish Journal of Cancer, 2007
- Bevacizumab in Combination With Oxaliplatin, Fluorouracil, and Leucovorin (FOLFOX4) for Previously Treated Metastatic Colorectal Cancer: Results From the Eastern Cooperative Oncology Group Study E3200Journal of Clinical Oncology, 2007
- Preparing the “Soil”: The Premetastatic NicheCancer Research, 2006
- Tumour‐associated angiogenesis in human colorectal cancerColorectal Disease, 2006
- The vascular endothelial growth factor receptor (VEGFR‐1) supports growth and survival of human breast carcinomaInternational Journal of Cancer, 2006
- Microvessel density and VEGF expression are prognostic factors in colorectal cancer. Meta-analysis of the literatureBritish Journal of Cancer, 2006
- Vascular endothelial growth factor receptor-1 mediates migration of human colorectal carcinoma cells by activation of Src family kinasesBritish Journal of Cancer, 2006
- Signal transduction by VEGF receptors in regulation of angiogenesis and lymphangiogenesisExperimental Cell Research, 2006
- Quantification of angiogenesis in solid human tumours: an international consensus on the methodology and criteria of evaluationEuropean Journal of Cancer, 1996
- Prognostic value of the number of metastatic lymph nodes in gastric cancer with radical surgeryJournal of Surgical Oncology, 1993